Nasdaq To Delist Company Run By Drug Price-Gouger Shkreli
One of the biotech companies run by Martin Shkreli, the drug price-gouger charged with securities fraud last week, has been told that its stock will be delisted by Nasdaq because of Shkreli's arrest and other factors.